UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 567

Sortiert nach

In Vitro Generation of Antigen-Specific T Cells from Induced Pluripotent Stem Cells of Antigen-Specific T Cell Origin

Methods in molecular biology (Clifton, N.J.), 2016, Vol.1393, p.67

Kaneko, Shin

2016

Link zum Volltext

Verfügbarkeit prüfen

Induced pluripotent stem cell-derived natural killer cells gene-modified to express chimeric antigen receptor-targeting solid tumors

International journal of hematology, 2021-11, Vol.114 (5), p.572-579

2021

Link zum Volltext

Verfügbarkeit prüfen

Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells

Stem cell reports, 2016-02, Vol.6 (2), p.213-227

2016

Link zum Volltext

Verfügbarkeit prüfen

Mental Health Survey of Truck Drivers

Nippon eiseigaku zasshi, 2014, Vol.69 (3), p.199-204

KANEKO, Shin-ya

2014

Link zum Volltext

Verfügbarkeit prüfen

Basic Research and Clinical Development of Regenerative Immunotherapy Using iPS Cells

Gan to kagaku ryoho, 2023-05, Vol.50 (5), p.571

2023

Link zum Volltext

Verfügbarkeit prüfen

Agile OLT-protection method based on backup wavelength and discovery process for resilient WDM/TDM-PON

2014 The European Conference on Optical Communication (ECOC), 2014, p.1-3

2014

Link zum Volltext
IEEE_Xplore

O13-5 Rejuvenated BCMA-specific CD8αβ+ memory T cells to treat multiple myeloma using induced pluripotent stem cell technology

Annals of oncology, 2023-11, Vol.34, p.S1389-S1390

2023

Link zum Volltext

Verfügbarkeit prüfen

To Be Immunogenic, or Not to Be: Thatas the iPSC Question

Cell stem cell, 2013-04, Vol.12 (4), p.385-386

2013

Link zum Volltext

Verfügbarkeit prüfen

iPSC-Derived HLA-A2 CAR Tregs Showed Suppression of GvHD in a Xenograft Model

Blood, 2022-11, Vol.140 (Supplement 1), p.2365-2366

2022

Link zum Volltext

Verfügbarkeit prüfen

Immune cell therapy using iPS cells

Rinshō ketsueki, 2018, Vol.59 (2), p.225

2018

Link zum Volltext

Verfügbarkeit prüfen

Development of B-cell maturation antigen (BCMA)-specific CD8 + cytotoxic T lymphocytes using induced pluripotent stem cell technology for multiple myeloma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2542-2542

2022

Link zum Volltext

Verfügbarkeit prüfen

Rejuvenated BCMA-Specific CD8 + Cytotoxic T Lymphocytes Derived from Antigen-Specific Induced Pluripotent Stem Cells : Immunotherapeutic Application in Multiple Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.75-75

2021

Link zum Volltext

Verfügbarkeit prüfen

The Journal of Gene MedicineJapanese Society of Gene Therapy (JSGT) Young Investigator Award from 2009

The journal of gene medicine, 2010-09, Vol.12 (9), p.790-791

Kaneko, Shin

2010

Link zum Volltext

Verfügbarkeit prüfen

Sustainable Antiviral Efficacy of Rejuvenated HIV-Specific Cytotoxic T Lymphocytes Generated from Induced Pluripotent Stem Cells

Journal of virology, 2022-03, Vol.96 (6), p.e0221721-e0221721

2022

Link zum Volltext

Verfügbarkeit prüfen

Recycling of printed circuit boards by robot manipulator: A Deep Learning Approach

2021 IEEE International Symposium on Robotic and Sensors Environments (ROSE), 2021, p.1-5

2021

Link zum Volltext

Verfügbarkeit prüfen

Guided Polarization of iPSC-Derived CD4SP Helper T Cells By CRISPR/Cas9-Based Genome-Editing

Blood, 2019-11, Vol.134 (Supplement_1), p.1937-1937

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3585: T cell receptor-stabilized regenerated CD8ab cytotoxic T lymphocytes for cancer immunotherapy

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3585-3585

2018

Link zum Volltext

Verfügbarkeit prüfen

Reliable [lambda]-Tuning OLT-Protection Method Based on Backup-Wavelength Pre-assignment and Discovery Process for Resilient WDM/TDM-PONs

Journal of lightwave technology, 2015-04, Vol.33 (8), p.1617

2015

Link zum Volltext

Verfügbarkeit prüfen

P-083: Rejuvenated BCMA-specific CD8+ Cytotoxic T lymphocytes derived from induced pluripotent stem cells for treatment of Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2021-10, Vol.21, p.S84-S84

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1432: Enhanced effector responses of regenerated CAR-T cells derived from genome edited iPSCs

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1432-1432

2019

Link zum Volltext

Verfügbarkeit prüfen

1220 Development of B cell maturation antigen (BCMA)-specific CD8+ cytotoxic T lymphocytes using induced pluripotent stem cell technology for multiple myeloma

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1265-A1265

2022

Link zum Volltext

Verfügbarkeit prüfen

Junctional Adhesion Molecule 2 Intensifies T Lymphopoiesis of Hematopoietic Stem Cells By Facilitating Notch/Delta Signaling

Blood, 2017-12, Vol.130 (Suppl_1), p.635-635

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 6347: Immunotherapeutic application of induced pluripotent stem cell technology: Rejuvenated BCMA-specific CD8+T cells for multiple myeloma

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.6347-6347

2022

Link zum Volltext

Verfügbarkeit prüfen

Mental Health Survey of Truck Drivers

Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene), 2014, Vol.69(3), pp.199-204

KANEKO, Shin-ya

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2550: Generation of CAR-iPS-T cells expressing CD8β

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2550-2550

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 567

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(318)
Mit Volltextzugriff
(525)

Publikationsform

Sprache

Englisch
(411)
Japanisch
(243)
Koreanisch
(7)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

In Vitro Generation of Antigen-Specific T Cells from Induced Pluripotent Stem Cells of Antigen-Specific T Cell Origin

Induced pluripotent stem cell-derived natural killer cells gene-modified to express chimeric antigen receptor-targeting solid tumors

Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells

Mental Health Survey of Truck Drivers

Basic Research and Clinical Development of Regenerative Immunotherapy Using iPS Cells

Agile OLT-protection method based on backup wavelength and discovery process for resilient WDM/TDM-PON

O13-5 Rejuvenated BCMA-specific CD8αβ+ memory T cells to treat multiple myeloma using induced pluripotent stem cell technology

To Be Immunogenic, or Not to Be: Thatas the iPSC Question

iPSC-Derived HLA-A2 CAR Tregs Showed Suppression of GvHD in a Xenograft Model

Immune cell therapy using iPS cells

Development of B-cell maturation antigen (BCMA)-specific CD8 + cytotoxic T lymphocytes using induced pluripotent stem cell technology for multiple myeloma

Rejuvenated BCMA-Specific CD8 + Cytotoxic T Lymphocytes Derived from Antigen-Specific Induced Pluripotent Stem Cells : Immunotherapeutic Application in Multiple Myeloma

The Journal of Gene MedicineJapanese Society of Gene Therapy (JSGT) Young Investigator Award from 2009

Sustainable Antiviral Efficacy of Rejuvenated HIV-Specific Cytotoxic T Lymphocytes Generated from Induced Pluripotent Stem Cells

Recycling of printed circuit boards by robot manipulator: A Deep Learning Approach

Guided Polarization of iPSC-Derived CD4SP Helper T Cells By CRISPR/Cas9-Based Genome-Editing

Abstract 3585: T cell receptor-stabilized regenerated CD8ab cytotoxic T lymphocytes for cancer immunotherapy

Reliable [lambda]-Tuning OLT-Protection Method Based on Backup-Wavelength Pre-assignment and Discovery Process for Resilient WDM/TDM-PONs

P-083: Rejuvenated BCMA-specific CD8+ Cytotoxic T lymphocytes derived from induced pluripotent stem cells for treatment of Multiple Myeloma

Abstract 1432: Enhanced effector responses of regenerated CAR-T cells derived from genome edited iPSCs

1220 Development of B cell maturation antigen (BCMA)-specific CD8+ cytotoxic T lymphocytes using induced pluripotent stem cell technology for multiple myeloma

Junctional Adhesion Molecule 2 Intensifies T Lymphopoiesis of Hematopoietic Stem Cells By Facilitating Notch/Delta Signaling

Abstract 6347: Immunotherapeutic application of induced pluripotent stem cell technology: Rejuvenated BCMA-specific CD8+T cells for multiple myeloma

Mental Health Survey of Truck Drivers

Abstract 2550: Generation of CAR-iPS-T cells expressing CD8β

Aktive Filter

Suchergebnisse filtern